Platelet Factor 4: An Inhibitor of Collagenase
- 3 March 1978
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 199 (4332), 991-992
- https://doi.org/10.1126/science.203038
Abstract
Human platelet factor 4 (PF4) is known to bind to heparin and inhibit its anticoagulant effect. This factor also inhibits the enzyme collagenase derived from cultured human skin and collagenase extracted from human granulocytes. The addition of heparin to the PF4-collagenase assay system has no effect on the observed inhibition of collagenase. Thus PF4 inhibits collagenase, in addition to neutralizing heparin.Keywords
This publication has 17 references indexed in Scilit:
- Development of a radioimmunoassay for human platelet factor 4Thrombosis Research, 1977
- Tumor Cell Collagenase and Its Inhibition by a Cartilage-Derived Protease InhibitorScience, 1977
- Release of platelet factor 4 (PF4) measured by a polybrene® assay in response to in vitro platelet damageThrombosis Research, 1977
- Collagenase inhibition by cationic proteins derived from cartilage and aortaBiochemical and Biophysical Research Communications, 1976
- A radioimmunoassay for platelet factor 4Thrombosis Research, 1976
- The rapid induction by phytohemagglutinin of increased α-aminoisobutyric acid uptake by lymphocytesJCI Insight, 1971
- Platelet Factor 4 and Adenosine Diphosphate Release during Human Platelet AggregationNature, 1969
- Degradation of collagen by a human granulocyte collagenolytic systemJCI Insight, 1968
- Human Granulocyte CollagenaseScience, 1968
- Release of platelet factor 4 by adenosine diphosphate and other platelet-aggregating agents.BMJ, 1968